LNC Technology Platform
Lipid Nano-Crystal (LNC) Delivery Platform
Matinas BioPharma's differentiated lipid nano-crystal (LNC) drug delivery platform has the potential to address delivery issues associated with a range of therapeutic types, including small molecules, oligonucleotides, proteins, peptides, vaccines, as well as the targeted delivery of gene editing technologies.
- Highly stable lipid nano-crystal particles
- Layered sheet design provides protection to drug cargo from harsh environmental conditions or enzymes
- Clinically validated in multiple clinical studies
Ability to Deliver a Broad Range of Molecuels
- Small molecules
- Gene editing technologies
For more information about our LNC delivery platform or to find out how we can formulate your drug candidate, please contact us.